🚨 Shockingly, NAFLD affects ~10% of 🇺🇸 🍔 adolescents, rising to 50% in obese males. Histopathologically, >5% steatosis and may lead to increased risk of 🔄 cirrhosis and liver cancer. Time for urgent #prevention and #intervention ! #HistopathHighlight #path4people #exercise
Exciting News! Chella Krishnan group publishes in Iscience: 'Hepatokine ITIH3 protects against hepatic steatosis by downregulating mitochondrial bioenergetics and de novo lipogenesis'. (UC College of Medicine, Karthick Chella-Krishnan, PhD)
Insulin resistance is implicated in both the pathogenesis of #MASLD and its progression from steatosis to steatohepatitis, cirrhosis, and even hepatocellular carcinoma. ADA Professional Publications American Diabetes Association
diabetesjournals.org/spectrum/artic…
Veeral Ajmera reviewing #NoninvasiveTesting for hepatic steatosis and #fibrosis in #MASLD & #MASH MASLD Research Center at UC San Diego Health Sciences MASH Preceptorship
💠thresholds differ across studies- what cut points are highest yield?
💠know the limitations of each NIT
📑 Aspirin 💊 is associated with a ⬇️ incidence of liver disease in men‼️
🟢11.2% ⬇️ risk liver disease in patients w aspirin use & no preexisting liver disease
🟢Men benefited most: 18.2% ⬇️ risk liver disease and 9.4% ⬇️ risk steatosis
#LiverTwitter
journals.lww.com/hepcomm/fullte…